Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Azacitidine × CNS × Clear all

Phase

Phase 1 4 Phase 1/2 3 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Myeloid 2 CNS 1

Conditions

Ependymoma 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 14 Temozolomide 11 Radiotherapy 7 fluciclovine F-18 6 Specimen Handling 5 Bevacizumab 5 fluorodopa F 18 4 Fluorodeoxyglucose F18 4 Ferrosoferric Oxide 4 Biopsy 4 gallium Ga 68 dotatate 3 abemaciclib 3 Topotecan 3 Pemetrexed 3 Methotrexate 3 Ketoconazole 3 Irinotecan 3 Everolimus 3 Cyclophosphamide 3 posaconazole 2 poly ICLC 2 olaparib 2 niraparib 2 Vincristine 2 Tissue Array Analysis 2 Therapeutics 2 Surgical Procedures, Operative 2 Standard of Care 2 Rituximab 2 Radiosurgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02940483 2018-11-30

5-AZA

The University of Texas Health Science Center, Houston

Phase EARLY_PHASE1 Completed

Brain Neoplasms, Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡